Patients with Dunnigan disease (FPLD2) with a pathogenic variant affecting exon 8 of the LMNA gene are considered to have the classic disease, whereas those with variants in other exons manifest the “atypical” disease. This evidence concerns the gene LMNA and familial partial lipodystrophy, Dunnigan type.